Literature DB >> 15104198

Aspirin intolerance and allergy to house dust mites: important factors associated with development of severe asthma.

Maciej Kupczyk1, Izabela Kupryś, Paweł Górski, Piotr Kuna.   

Abstract

BACKGROUND: Although the occurrence of bronchial asthma is still increasing, the possible factors associated with the development of severe asthma have not been completely determined.
OBJECTIVE: To measure the incidence of severe asthma and its determinants in outpatients. Aspirin intolerance, house dust mite (HDM) allergy, male sex, age older than 65 years, and duration of asthma exceeding 10 years were investigated as factors potentially related to the severity of asthma.
METHODS: The study population included 598 women and 408 men, mean age of 44.59 years (SD +/- 16.45 years), randomly chosen from patients with asthma under follow-up surveillance in an outpatient clinic. Their medical histories were reviewed; spirometry and skin prick tests were performed.
RESULTS: The asthma was diagnosed as intermittent in 35.39%, persistently mild in 33.40%, moderate in 23.76%, and severe in 7.45% of the study cohort. In the patients with atopy, HDM allergy was a significant factor associated with the development of severe asthma [odds ratio (OR) = 5.65]. Of the 1,006 patients, 341 (33.90%) had had asthma for at least 10 years, which was a significant factor in the overall study group (OR = 3.64). We found 95 cases (9.44% of the study group) of aspirin intolerance, including 23 of the 75 patients with severe asthma (30.67%; OR = 5.44). Logistic regression analysis showed that aspirin intolerance was most closely associated with severe asthma (beta = 5.79; P < .001).
CONCLUSIONS: The data from this study show that aspirin intolerance, HDM allergy, and asthma duration exceeding 10 years are major factors associated with severe asthma in outpatients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104198     DOI: 10.1016/S1081-1206(10)61782-6

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  7 in total

1.  Authors' Reply to Yilmaz and Türk: "Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives".

Authors:  Maciej Kupczyk; Piotr Kuna
Journal:  Drugs       Date:  2017-11       Impact factor: 9.546

2.  Therapeutic options for severe asthma.

Authors:  Jilcy Mathew; Wilbert S Aronow; Dipak Chandy
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

3.  Rhinosinusitis and aspirin-exacerbated respiratory disease.

Authors:  Maria L Garcia Cruz; M Alejandro Jimenez-Chobillon; Luis M Teran
Journal:  J Allergy (Cairo)       Date:  2012-07-04

4.  Skin test reactivity to indoor allergens correlates with asthma severity in jeddah, saudi arabia.

Authors:  Emad A Koshak
Journal:  Allergy Asthma Clin Immunol       Date:  2006-03-15       Impact factor: 3.406

Review 5.  Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis.

Authors:  Joanna Makowska; Anna Lewandowska-Polak; Marek L Kowalski
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

6.  Extrabronchial symptoms and late phase reaction enhance the diagnostic value of aspirin bronchial challenge.

Authors:  Damian Tworek; Ewa Zielińska-Wyderkiewicz; Paweł Górski; Piotr Kuna
Journal:  Postepy Dermatol Alergol       Date:  2015-12-11       Impact factor: 1.837

7.  Mite-induced inflammation: More than allergy.

Authors:  Mario Sánchez-Borges; Enrique Fernández-Caldas; Arnaldo Capriles-Hulett; Fernan Caballero-Fonseca
Journal:  Allergy Rhinol (Providence)       Date:  2012-05-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.